Yi Zeng

Yi Zeng holds a Ph.D. in Chemical Engineering from Brigham Young University and a BS in Polymer Science and Chemical Engineering from Tsinghua University. With extensive experience in the pharmaceutical industry, Yi Zeng has served in various roles at Axsome Therapeutics, Inc., including Sr. Director, Director, and Associate Director of CMC. Previously, Yi Zeng was the Director of Research and Development and Manager of Formulation at PuraCap Pharmaceutical, LLC. Additional experience includes positions as Sr. Scientist at Catalent Pharma Solutions and Celator Pharmaceuticals, as well as Research Associate at Altria.